Home
About
Overview
Sharing Data
ORCID
Help
History (4)
Complications of ablative therapies in lung cancer.
Event-free survival as a predictor of overall survival and recurrence burden of patients with non-small cell lung cancer receiving neoadjuvant therapy.
Interneuron-specific dual-AAV SCN1A gene replacement corrects epileptic phenotypes in mouse models of Dravet syndrome.
Real-World Neoadjuvant Treatment Patterns and Outcomes in Resected Non-Small-Cell Lung Cancer.
See All 4 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Complications of ablative therapies in lung cancer.
Complications of ablative therapies in lung cancer. Clin Lung Cancer. 2008 Mar; 9(2):122-6.
View in:
PubMed
subject areas
Aged, 80 and over
Carcinoma, Non-Small-Cell Lung
Catheter Ablation
Empyema
Female
Humans
Lung Neoplasms
Male
Microwaves
Middle Aged
Neoplasm Recurrence, Local
Neoplasm, Residual
Pneumothorax
Tomography, X-Ray Computed
authors with profiles
Jessica Donington